Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

Asahi Kasei Bioprocess America Inc. (AKBA), a leader in advanced filtration and fluid management solutions for the ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Asahi Kasei Bioprocess America, Inc. (AKBA), a leader in advanced filtration and fluid management solutions for the biopharmaceutical industry, has appointed Chris Rombach as its President.

IQVIA has seen an increase of 58.97% in its revenues since 2017. Click here to read more about IQV stock and why it is rated ...

Silo currently has patents issued and numerous expanded patent applications pending for SPC-15, a technology that was ...

Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development ...

Company confirms topline results for COAST anticipated in early 2Q CY25 ...

Bluejay’s lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).